Drug Approval | November 20, 2023
Teva announces approval of a generic version of Forteo in US
This approval showcases Teva’s proven strengths in complex generic formulations development and device engineering
This approval showcases Teva’s proven strengths in complex generic formulations development and device engineering
Nerivio is a prescription-based non-invasive device intended for acute and prophylactic (preventive) treatment of migrain
We are redesigning Bayer to focus only on what’s essential for our mission, ‘Health for all, hunger for none’”
Dr Reddy’s Laboratories recorded revenue of Rs 6,880.20 crore during the quarter
Punit has more than 20 years of experience in the generics and branded pharmaceutical marketplace
Bains has stepped down from his role on the Biocon Board as an Independent Director with immediate effect
Norelgestromin and Ethinyl Estradiol Transdermal System, 150 mcg/35 mcg per day had annual sales of US $330 million in the United States
Low-leveraged balance sheets, sizeable liquidity to keep credit profiles stable
This collaboration marks a significant milestone in countering the disease burden by enhancing access to products for patients in the US
The facility has a potential for capacity expansion up to 2 billion tablets/capsules per year
Subscribe To Our Newsletter & Stay Updated
